|
|
Volumn 6, Issue 4, 1997, Pages 367-387
|
|
Recent advances in the identification of α1- and α2-adrenoceptor subtypes: Therapeutic implications
a
|
|
Author keywords
benign prostatic hyperplasia; hypertension; vascular tone; (1L) adrenoceptor; 1 adrenoceptor; 2 adrenoceptor
|
|
Indexed keywords
1,4 DIHYDRO 2,6 DIMETHYL 4 (4 NITROPHENYL) 3,5 PYRIDINEDICARBOXYLIC ACID 3 AMIDE 5 [3 (4,4 DIPHENYL 1 PIPERIDINYL)PROPYL]AMIDE;
2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE;
2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE;
2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN;
3 [3 [4 [4 FLUORO 2 (2,2,2 TRIFLUOROETHOXY)PHENYL] 1 PIPERAZINYL]PROPYL] 5 METHYL 1H PYRIMIDINE 2,4 DIONE;
5 METHYLURAPIDIL;
7 CHLORO 3,4,5,6 TETRAHYDRO 4 METHYL 2 VINYLTHIENO[4,3,2 EF][3]BENZAZEPINE;
8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE;
8 [3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]PROPYLCARBAMOYL] 3 METHYLFLAVONE;
ALPHA 1 ADRENERGIC RECEPTOR;
ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA 1L ADRENERGIC RECEPTOR;
ALPHA 2 ADRENERGIC RECEPTOR;
ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRL 49862;
CARVEDILOL;
CYCLAZOSIN;
DOXAZOSIN;
GG 818;
IMILOXAN;
INDORAMIN;
NIGULDIPINE;
OXYMETAZOLINE;
PRAZOSIN;
RAUWOLSCINE;
RECEPTOR SUBTYPE;
SKF 105854;
SL 890591;
TAMSULOSIN;
TERAZOSIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
YOHIMBINE;
ANIMAL MODEL;
ATTENTION DEFICIT DISORDER;
BLOOD VESSEL TONE;
CENTRAL NERVOUS SYSTEM;
CLASSIFICATION;
CLINICAL TRIAL;
DRUG DESIGN;
DRUG RECEPTOR BINDING;
DRUG SELECTIVITY;
GENE MUTATION;
GLAUCOMA;
HUMAN;
HYPERTENSION;
MOLECULAR CLONING;
NONHUMAN;
OPIATE ADDICTION;
ORTHOSTATIC HYPOTENSION;
PROSTATE HYPERTROPHY;
REVIEW;
VERTIGO;
WITHDRAWAL SYNDROME;
|
|
EID: 0030901734
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.6.4.367 Document Type: Review |
|
Times cited : (51)
|
|
References (166)
|
